BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 27206514)

  • 1. Comparing the Recurrence of Vulvovaginal Candidiasis in Patients Undergoing Prophylactic Treatment with Probiotic and Placebo During the 6 Months.
    Davar R; Nokhostin F; Eftekhar M; Sekhavat L; Bashiri Zadeh M; Shamsi F
    Probiotics Antimicrob Proteins; 2016 Sep; 8(3):130-3. PubMed ID: 27206514
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparing the Effect of Probiotic and Fluconazole on Treatment and Recurrence of Vulvovaginal Candidiasis: a Triple-Blinded Randomized Controlled Trial.
    Mollazadeh-Narestan Z; Yavarikia P; Homayouni-Rad A; Samadi Kafil H; Mohammad-Alizadeh-Charandabi S; Gholizadeh P; Mirghafourvand M
    Probiotics Antimicrob Proteins; 2023 Oct; 15(5):1436-1446. PubMed ID: 36198994
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improved treatment of vulvovaginal candidiasis with fluconazole plus probiotic Lactobacillus rhamnosus GR-1 and Lactobacillus reuteri RC-14.
    Martinez RC; Franceschini SA; Patta MC; Quintana SM; Candido RC; Ferreira JC; De Martinis EC; Reid G
    Lett Appl Microbiol; 2009 Mar; 48(3):269-74. PubMed ID: 19187507
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lactobacillus plantarum P17630 for preventing Candida vaginitis recurrence: a retrospective comparative study.
    De Seta F; Parazzini F; De Leo R; Banco R; Maso GP; De Santo D; Sartore A; Stabile G; Inglese S; Tonon M; Restaino S
    Eur J Obstet Gynecol Reprod Biol; 2014 Nov; 182():136-9. PubMed ID: 25305660
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vaginal and oral use of probiotics as adjunctive therapy to fluconazole in patients with vulvovaginal candidiasis: A clinical trial on Iranian women.
    Vahedpoor Z; Abastabar M; Sehat M; Talebian P; Felfelian Fini T; Dastanpour Z; Haghani I; Chelongarian R; Nazeri M
    Curr Med Mycol; 2021 Sep; 7(3):36-43. PubMed ID: 35528620
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Maintenance fluconazole therapy for recurrent vulvovaginal candidiasis.
    Sobel JD; Wiesenfeld HC; Martens M; Danna P; Hooton TM; Rompalo A; Sperling M; Livengood C; Horowitz B; Von Thron J; Edwards L; Panzer H; Chu TC
    N Engl J Med; 2004 Aug; 351(9):876-83. PubMed ID: 15329425
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [INVESTIGATION ON ANTIFUNGAL SUSCEPTIBILITY OF CANDIDA YEASTS IN PREGNANT PATIENTS WITH CONFIRMED VULVOVAGINAL CANDIDIASIS AND THEIR NEWBORNS.].
    Chokoeva A; Kouzmanov A; Ivanova Z; Zisova L; Amalie G; Petleshkova P; Miteva-Katrandzhieva T; Krasteva M; Uchikova E
    Akush Ginekol (Sofiia); 2016; 55(4):20-29. PubMed ID: 29370489
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of
    Mändar R; Sõerunurk G; Štšepetova J; Smidt I; Rööp T; Kõljalg S; Saare M; Ausmees K; Le DD; Jaagura M; Piiskop S; Tamm H; Salumets A
    Benef Microbes; 2023 Apr; 14(2):143-152. PubMed ID: 36856121
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of vulvovaginal candidiasis: a review of the literature.
    Dovnik A; Golle A; Novak D; Arko D; Takač I
    Acta Dermatovenerol Alp Pannonica Adriat; 2015; 24(1):5-7. PubMed ID: 25770305
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Guideline: vulvovaginal candidosis (AWMF 015/072), S2k (excluding chronic mucocutaneous candidosis).
    Mendling W; Brasch J; Cornely OA; Effendy I; Friese K; Ginter-Hanselmayer G; Hof H; Mayser P; Mylonas I; Ruhnke M; Schaller M; Weissenbacher ER
    Mycoses; 2015 Mar; 58 Suppl 1():1-15. PubMed ID: 25711406
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A phase 2, randomized, double-blind, placebo-controlled, dose-ranging study to evaluate the efficacy and safety of orally administered VT-1161 in the treatment of recurrent vulvovaginal candidiasis.
    Brand SR; Degenhardt TP; Person K; Sobel JD; Nyirjesy P; Schotzinger RJ; Tavakkol A
    Am J Obstet Gynecol; 2018 Jun; 218(6):624.e1-624.e9. PubMed ID: 29534874
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An evaluation of butoconazole nitrate 2% site release vaginal cream (Gynazole-1) compared to fluconazole 150 mg tablets (Diflucan) in the time to relief of symptoms in patients with vulvovaginal candidiasis.
    Seidman LS; Skokos CK
    Infect Dis Obstet Gynecol; 2005 Dec; 13(4):197-206. PubMed ID: 16338779
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of vitamin B complex as an adjuvant therapy for the treatment of complicated vulvovaginal candidiasis: An in vivo and in vitro study.
    Sun MG; Huang Y; Xu YH; Cao YX
    Biomed Pharmacother; 2017 Apr; 88():770-777. PubMed ID: 28157653
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of Candida glabrata and its response to boric acid vaginal suppositories in comparison with oral fluconazole in patients with diabetes and vulvovaginal candidiasis.
    Ray D; Goswami R; Banerjee U; Dadhwal V; Goswami D; Mandal P; Sreenivas V; Kochupillai N
    Diabetes Care; 2007 Feb; 30(2):312-7. PubMed ID: 17259500
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Short-course treatment of vulvovaginal candidiasis: comparative study of fluconazole and intra-vaginal fenticonazole].
    Murina F; Graziottin A; Felice R; Di Francesco S; Mantegazza V
    Minerva Ginecol; 2012 Apr; 64(2):89-94. PubMed ID: 22481619
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lactic acid bacteria colonization and clinical outcome after probiotic supplementation in conventionally treated bacterial vaginosis and vulvovaginal candidiasis.
    Ehrström S; Daroczy K; Rylander E; Samuelsson C; Johannesson U; Anzén B; Påhlson C
    Microbes Infect; 2010 Sep; 12(10):691-9. PubMed ID: 20472091
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Randomised clinical trial in women with Recurrent Vulvovaginal Candidiasis: Efficacy of probiotics and lactoferrin as maintenance treatment.
    Russo R; Superti F; Karadja E; De Seta F
    Mycoses; 2019 Apr; 62(4):328-335. PubMed ID: 30565745
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Pulsatilla decoction inhibits vulvovaginal Candida albicans proliferation and reduces inflammatory cytokine levels in vulvovaginal candidiasis mice].
    Xia D; Zhang M; Shi G; Xu Z; Wu D; Shao J; Wang T; Wang C
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2016 Feb; 32(2):153-7. PubMed ID: 26927371
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is it possible to prevent recurrent vulvovaginitis? The role of Lactobacillus plantarum I1001 (CECT7504).
    Palacios S; Espadaler J; Fernández-Moya JM; Prieto C; Salas N
    Eur J Clin Microbiol Infect Dis; 2016 Oct; 35(10):1701-8. PubMed ID: 27393491
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Role of Probiotics in the Treatment of Vulvovaginal Candidiasis: A Systematic Review and Meta-Analysis.
    Zahedifard T; Khadivzadeh T; Rakhshkhorshid M
    Ethiop J Health Sci; 2023 Sep; 33(5):881-890. PubMed ID: 38784519
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.